[A10-03] Aromatase inhibitors in female breast cancer

Last updated 15.11.2016

Project no.:
A10-03

Commission:
Commission awarded on 19.07.2010 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Cancer

15.11.2016

Longer survival, later recurrences / Evidence for late-stage disease much poorer

Press release

Executive summary of the final report: Aromatase inhibitors in female breast cancer

EN, PDF, 190 kB, PDF

published on Nov 15, 2016
Final report: Aromatase inhibitors in female breast cancer

DE, PDF, 4 MB, PDF

published on Nov 15, 2016
Documentation and evaluation of comments on the preliminary report: Aromatase inhibitors in female breast cancer

DE, PDF, 3 MB, PDF

published on Nov 15, 2016
Executive summary of the preliminary report: Aromatase inhibitors in female breast cancer

PDF, 194 kB, PDF

published on Apr 8, 2016
Preliminary report: Aromatase inhibitors in female breast cancer

PDF, 5 MB, PDF

published on Apr 8, 2016
Report plan version 1.0: Aromatase inhibitors in female breast cancer

DE, PDF, 187 kB, PDF

published on Dec 7, 2012
Documentation and evaluation of comments on the preliminary report plan: Aromatase inhibitors in female breast cancer

DE, PDF, 2 MB, PDF

published on Dec 7, 2012
Preliminary report plan: Aromatase inhibitors in female breast cancer

DE, PDF, 171 kB, PDF

published on Apr 10, 2012

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.